Related Experiment Video

Updated: May 5, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K

siRNA preparations in gene therapy of melanoma

Joanna Bogusławska1, Maciej Małecki

  • 1Department of Applied Pharmacy and Bioengineering, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland, 0048 572-09-65, maciej.malecki@wum.edu.pl.

Medycyna Wieku Rozwojowego
|December 4, 2013
PubMed

Insights

Small interfering RNA (siRNA) offers a promising gene therapy for melanoma, a challenging skin cancer. Research is ongoing to optimize siRNA delivery and gene silencing for effective and safe cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Melanoma incidence is rising, posing a significant challenge in cancer treatment.
  • Gene therapy is an emerging field for cancer treatment.
  • RNA interference (RNAi) using small interfering RNA (siRNA) allows for targeted gene expression inhibition.

Purpose of the Study:

  • To explore the potential of siRNA as a gene therapy for melanoma.
  • To investigate the critical factors for successful siRNA-based cancer treatment, including transfection efficiency and gene silencing levels.

Main Methods:

  • Review of current preclinical and clinical studies on siRNA for cancer therapy.
  • Focus on RNA interference mechanisms and gene silencing principles.
  • Assessment of transfection efficiency and target gene knockdown.

Main Results:

  • siRNA demonstrates potential for targeted gene inhibition in cancer cells.
  • Transfection efficiency and the degree of gene silencing are key determinants of siRNA efficacy.
  • Ongoing studies are evaluating the safety and effectiveness of siRNA preparations.

Conclusions:

  • siRNA-based gene therapy is a developing strategy for melanoma treatment.
  • Further research and clinical trials are necessary to establish siRNA as a safe and effective therapeutic option for melanoma patients.

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.2K
Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

7.9K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.2K
Gene Therapy00:59

Gene Therapy

4.5K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
13.4K